UNSPSC 51141565: Losigamone

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51141565

Definition

This classification denotes an anticonvulsant agent with the molecular formula C12H11ClO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 84R8O3QM2G, chemically known as 2(5h)-furanone, 5-((2-chlorophenyl)hydroxymethyl)-4-methoxy-, (r*,s*)- but generally known as losigamone, which bears US NIH Compound Identifier 60572. European Medicines Agency schedules Losigamone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08594MIG.

Read the full definition

The term LOSIGAMONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). LOSIGAMONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, LOSIGAMONE remains the US FDA Preferred Term for this commodity. Losigamone bears US NLM identifiers UMLS ID C0083259 and NCI Concept Code C90707. SMILES: COC1=CC(=O)OC1C(C2=CC=CC=C2CL)O.

About UNSPSC 51141565

UNSPSC 51141565 Losigamone is a Commodity code that maps to pharmaceutical harm-reduction products, though the recent state and local procurement activity under this code reflects a mismatch between the nominal scope and what is actually being bought. Seminole County, Florida has posted an IFB for naloxone and safe drug deactivation systems rather than losigamone specifically, suggesting the code may be applied inconsistently or that the taxonomy classification does not track closely to the harm-reduction pharmaceutical products state and local health departments are actively sourcing. The scope of work under this code, as reflected in recent solicitation activity, centers on community health initiatives that supply opioid-overdose-reversal medications and drug disposal systems through quarterly deliveries to designated health facilities. Issuing bodies include county health departments and county procurement offices operating in support of public health missions.

The geographic activity concentrates in Florida, with Seminole County representing the primary recent posting. Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, delivered quarterly to the Seminole County Community Health Building in Sanford. Vendors must include all shipping and delivery costs in their bids, comply with E-Verify and drug-free workplace requirements, maintain workers' compensation and commercial general liability insurance, and accept a three-month probationary termination clause. The contract carries a two-year initial term with one-year renewal option and is potentially FEMA-funded, triggering federal environmental and compliance audits. No explicit set-aside designations are mentioned. The limited recent-opportunity visibility under this code suggests low overall procurement volume or inconsistent UNSPSC classification in state and local systems.

Quick answers

What is UNSPSC 51141565?

UNSPSC 51141565 is Losigamone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51141565?

UNSPSC 51141565 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51141565

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code